LOARGYS 5 mg/ml, solution for injection/for infusion bottle, 0.4 ml
Active ingredients: PEGZILARGINASE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusionbottle, 0.4 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOARGYS 5 mg/ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 0,4 ml
- Marketing authorisation holder
- IMMEDICA PHARMA (SUEDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65606323CIP73028328CIP133400930283288Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGZILARGINASEsolution | 5 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.